PAPER Fu Y, Yang Y, Shi J, Bishayee K, Lin L, Lin Y, Zhang Y, Ji L, Li C
SEARCH RESULTS
16509 RESULTS
PAPER Stage EC Jr, Svaldi D, Phillips M, Canela VH, Duran T, Goukasian N, Risacher SL, Saykin AJ, Apostolova LG, Alzheimer’s Disease Neuroimaging Initiative
Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis.
Alzheimers Res Ther. 2020 Aug 5;12(1):93. PubMed: 32758274PAPER Christensen MG, Damsgaard J, Fink-Jensen A
Use of ketogenic diets in the treatment of central nervous system diseases: a systematic review.
Nord J Psychiatry. 2021 Jan;75(1):1-8. Epub 2020 Aug 6 PubMed: 32757903PAPER Ibarra R, Radanovic M, Pais MV, Talib LL, Forlenza OV
AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State.
J Geriatr Psychiatry Neurol. 2020 Aug 6;:891988720944237. PubMed: 32757819PAPER Roquet A, Michel BF, Lemaire P
Alzheimer's disease disrupts domain-specific and domain-general processes in numerosity estimation.
J Clin Exp Neuropsychol. 2020 Sep;42(7):690-709. Epub 2020 Aug 5 PubMed: 32757739PAPER Ni YN, Kong L, Li XT, Xiao HH, Wu YT, Liang XC, Lin Y, Li WY, Deng Y, Li Y, Shi Y, Cheng L, Li HY, Ju RJ, Yang JX
Multifunctional osthole liposomes and brain targeting functionality with potential applications in a mouse model of Alzheimer's disease.
J Liposome Res. 2020 Aug 18;:1-12. PubMed: 32757676PAPER Roberts ER, Dossat AM, Del Mar Cortijo M, Brundin P, Wesson DW
Alterations in odor hedonics in the 5XFAD Alzheimer's disease mouse model and the influence of sex.
Behav Neurosci. 2020 Oct;134(5):407-416. Epub 2020 Aug 6 PubMed: 32757584PAPER Jahić A, Tušek Žnidarič M, Pintar S, Berbić S, Žerovnik E
The effect of three polyphenols and some other antioxidant substances on amyloid fibril formation by Human cystatin C.
Neurochem Int. 2020 Nov;140:104806. Epub 2020 Aug 3 PubMed: 32758584PAPER Hajjar I, Okafor M, McDaniel D, Obideen M, Dee E, Shokouhi M, Quyyumi AA, Levey A, Goldstein F
Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.
JAMA Netw Open. 2020 Aug 3;3(8):e2012252. PubMed: 32761160PAPER Drew DS, Muhammed K, Baig F, Kelly M, Saleh Y, Sarangmat N, Okai D, Hu M, Manohar S, Husain M
Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Brain. 2020 Aug 1;143(8):2502-2518. PubMed: 32761061PAPER Cibeira N, Maseda A, Lorenzo-López L, Rodríguez-Villamil JL, López-López R, Millán-Calenti JC
Application of light therapy in older adults with cognitive impairment: A systematic review.
Geriatr Nurs. 2020 Nov - Dec;41(6):970-983. Epub 2020 Aug 2 PubMed: 32758377Siobhan O'Connor
Invermay, Australia
Seeing into the Human Synapse: New Tools Illuminate Alzheimer’s Hot Spot
CONFERENCE COVERAGE 2020-08-08 Conference Coverage Without the millions of thriving synapses that link them, neurons in the brain are useless. The crumbling of these tiny connective structures is widely viewed as the proximal step to cognitive impairment in Alzheimer’s disease. Yet, re
FDA Accepts Aducanumab Application for Priority Review
RESEARCH NEWS 2020-08-08 Research News The fate of aducanumab now rests in the hands of regulators at the U.S. Food and Drug Administration (FDA). Biogen of Cambridge, Massachusetts, and Eisai Co. Ltd., Tokyo, announced on August 7 that the agency had accepted its Biologics Licen
James Nicoll, Delphine Boche on Paper Alert: Those PIGs! Spatial Transcriptomics Add Human Data
COMMENT As investigators focused on direct study of inflammatory processes in the human brain, we are impressed by the spectacular application of new technology to Alzheimer’s disease in this paper. The findings resonate in two specific ways with our own previous
Current Filters
- Date Range : Aug 2019 to Aug 2020 x